Cargando…

Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease limited to the lungs and associated with the histologic appearance of usual interstitial pneumonia (UIP) on surgical lung biopsy. The estimated prevalence in the United States is between 35,000 and 55,000 cases, and evidence sug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zisman, David A., Keane, Michael P., Belperio, John A., Strieter, Robert M., Lynch, Joseph P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120641/ https://www.ncbi.nlm.nih.gov/pubmed/16130230 http://dx.doi.org/10.1385/1-59259-940-0:003

Ejemplares similares

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis
por: Palchevskiy, Vyacheslav, et al.
Publicado: (2011)

CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection
por: Londhe, Vedang A, et al.
Publicado: (2005)

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
por: Addison, Christina L, et al.
Publicado: (2004)

The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease
por: Keane, Michael P, et al.
Publicado: (2002)

Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study
por: Saggar, Rajeev, et al.
Publicado: (2021)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Capillary Proliferation in Systemic‐Sclerosis‐Related Pulmonary Fibrosis: Association with Pulmonary Hypertension
por: Seki, Atsuko, et al.
Publicado: (2019)

Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis
por: Wu, Xiuju, et al.
Publicado: (2023)

Outcome and Prognostic Indicators of Patients with Hematopoietic Stem Cell Transplants Admitted to the Intensive Care Unit
por: Huynh, Thanh N., et al.
Publicado: (2009)

Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
por: Pan, Judong, et al.
Publicado: (2006)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
por: Todd, Jamie L., et al.
Publicado: (2020)

The Fibrosis Burden of Systemic Sclerosis
por: Keane, Michael P.
Publicado: (2019)

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
por: Todd, Jamie L., et al.
Publicado: (2022)

Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
por: Todd, Jamie L., et al.
Publicado: (2022)

Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement
por: Belperio, John A., et al.
Publicado: (2021)

Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI
por: Fleming, Hannah, et al.
Publicado: (2020)

Practical Imaging Interpretation in Patients Suspected of Having Idiopathic Pulmonary Fibrosis: Official Recommendations from the Radiology Working Group of the Pulmonary Fibrosis Foundation
por: Hobbs, Stephen, et al.
Publicado: (2021)

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
por: Todd, Jamie L., et al.
Publicado: (2019)

TRAIL-Dependent Resolution of Pulmonary Fibrosis
por: Habiel, David M., et al.
Publicado: (2018)

Dose considerations in the SO2-exposed exercising asthmatic.
por: Colucci, A V, et al.
Publicado: (1983)

Preoperative Cardiac Variables of Diastolic Dysfunction and Clinical Outcomes in Lung Transplant Recipients
por: Yadlapati, Ajay, et al.
Publicado: (2013)

Idiopathic pulmonary fibrosis: the radiologist’s role in making the diagnosis
por: Mohning, Michael P., et al.
Publicado: (2019)

Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis
por: Humphries, Stephen M., et al.
Publicado: (2022)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction
por: Shino, Michael Y., et al.
Publicado: (2018)

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
por: Crooks, Michael G., et al.
Publicado: (2015)

The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis
por: Liang, Jiurong, et al.
Publicado: (2022)

Fibrocytes and the pathogenesis of diffuse parenchymal lung disease
por: Mehrad, Borna, et al.
Publicado: (2012)

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
por: Collum, Scott D., et al.
Publicado: (2019)

The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
por: Murtha, Lucy A., et al.
Publicado: (2017)

24-Hour Hypoxia and Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
por: Rodrigues, Marcelo P., et al.
Publicado: (2017)

Reflux in idiopathic pulmonary fibrosis: treatment informed by an integrated approach
por: Jones, Rhys, et al.
Publicado: (2018)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis: A Review
por: Fahim, Ahmed, et al.
Publicado: (2011)

The significance of nanoparticles in particle-induced pulmonary fibrosis
por: Byrne, James D, et al.
Publicado: (2008)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2019)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_58b36o1l0vve1ggrjvi2llmv56